Application Of On-Sale Bar Of Patented Method Requires Completion Of All Steps Prior To Critical Date
Client Alert | 1 min read | 12.20.06
In Plumtree Software, Inc. v. Datamize, LLC (No. 06-1017; Dec. 18, 2006), the Federal Circuit vacates summary judgment of invalidity of Datamize's patents and remands for a determination of whether all of the steps of the patented method were actually performed before the critical date for an on-sale bar. The patented invention is for a method and computer program for creating other computer programs, which could be used to create an interactive kiosk system.
The patentee met with representatives of Ski Industry of America (SIA) before the critical date and offered to create a kiosk for an SIA tradeshow. Subsequently, and prior to the critical date, SIA sent a letter to the patentee confirming the patentee's participation in the trade show. The district court decided that an on-sale bar was triggered, because there was an agreement before the critical date that the patentee would provide a software/hardware package necessary to produce the interactive touch-screen information center as presented to SIA.
The Federal Circuit vacates the summary judgment, because the record does not clearly indicate (A) whether the agreement required use of the patented method, or (B) whether all of the steps of the patented method were performed before the critical date. The patentee began creating the kiosk system using the patented method prior to the critical date, but the kiosk system was not finished until after the critical date. Thus, the Federal Circuit remands for a determination of whether all of the steps of the patented method were performed prior to the critical date.
Insights
Client Alert | 15 min read | 08.20.25
In this eighth alert in our weekly series on the EU Pharma Package, we continue our overview of initiatives with respect to security of supply and shortage prevention and mitigation. Our last alert looked at how the Pharma Package seeks to address these issues. However, the Pharma Package does not exist in isolation, and in this alert we will discuss the interplay between its measures and those contained in other important EU initiatives such as the proposed Critical Medicines Act (CMA), and the Medicinal Countermeasures Strategy and the EU Stockpiling Strategy.
Client Alert | 2 min read | 08.19.25
Client Alert | 4 min read | 08.19.25
Forged Faces, Real Liability: Deepfake Laws Take Effect in Washington State and Pennsylvania
Client Alert | 1 min read | 08.19.25